Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debanjali Mitra

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Postgraduate Medicine|May 14, 2011
All-cause health care charges among managed care patients with constipation and comorbid irritable bowel syndromeDebanjali Mitra, Keith L Davis, Robert W Baran
Clinical Therapeutics|July 29, 2017
Patient-reported Quality of Life and Treatment Satisfaction in Patients With HR<sup>+</sup>/HER2<sup>-</sup> Advanced/Metastatic Breast CancerRobert Wood, Debanjali Mitra, Jonathan de Courcy, et al.
ESMO Open|December 7, 2017
Patient-reported pain severity, pain interference and health status in HR+/HER2- advanced/metastatic breast cancerRobert Wood, Debanjali Mitra, Jonathan de Courcy, et al.
Clinical Breast Cancer|December 5, 2017
Treatment Patterns and Outcomes of Patients With Metastatic ER<sup>+</sup>/HER-2<sup>-</sup> Breast Cancer: A Multicountry Retrospective Medical Record ReviewSamantha K Kurosky, Debanjali Mitra, Giovanni Zanotti, et al.
Breast Cancer Research and Treatment|July 29, 2017
Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancerFlorence R Wilson, Abhishek Varu, Debanjali Mitra, et al.
Journal of Clinical Gastroenterology|July 15, 2010
Direct economic burden of chronic hepatitis C virus in a United States managed care populationKeith L Davis, Debanjali Mitra, Jasmina Medjedovic, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 28, 2010
Treatment patterns and adherence among patients with chronic hepatitis C virus in a US managed care populationDebanjali Mitra, Keith L Davis, Cynthia Beam, et al.
Current Oncology (Toronto, Ont.)|January 27, 2021
Real-World Palbociclib Use in HR+/HER2- Advanced Breast Cancer in Canada: The IRIS StudyKatie Mycock, Lin Zhan, Gavin Taylor-Stokes, et al.
Annals of Clinical Biochemistry|May 12, 2016
The economic impact of poor sample quality in clinical chemistry laboratories: results from a global surveyErik P Erdal, Debanjali Mitra, Victor S Khangulov, et al.
BMC Gastroenterology|September 26, 2012
Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitisDebanjali Mitra, Paul Hodgkins, Linnette Yen, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Postgraduate Medicine|May 14, 2011
All-cause health care charges among managed care patients with constipation and comorbid irritable bowel syndromeDebanjali Mitra, Keith L Davis, Robert W Baran
Clinical Therapeutics|July 29, 2017
Patient-reported Quality of Life and Treatment Satisfaction in Patients With HR<sup>+</sup>/HER2<sup>-</sup> Advanced/Metastatic Breast CancerRobert Wood, Debanjali Mitra, Jonathan de Courcy, et al.
ESMO Open|December 7, 2017
Patient-reported pain severity, pain interference and health status in HR+/HER2- advanced/metastatic breast cancerRobert Wood, Debanjali Mitra, Jonathan de Courcy, et al.
Clinical Breast Cancer|December 5, 2017
Treatment Patterns and Outcomes of Patients With Metastatic ER<sup>+</sup>/HER-2<sup>-</sup> Breast Cancer: A Multicountry Retrospective Medical Record ReviewSamantha K Kurosky, Debanjali Mitra, Giovanni Zanotti, et al.
Breast Cancer Research and Treatment|July 29, 2017
Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancerFlorence R Wilson, Abhishek Varu, Debanjali Mitra, et al.
Journal of Clinical Gastroenterology|July 15, 2010
Direct economic burden of chronic hepatitis C virus in a United States managed care populationKeith L Davis, Debanjali Mitra, Jasmina Medjedovic, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 28, 2010
Treatment patterns and adherence among patients with chronic hepatitis C virus in a US managed care populationDebanjali Mitra, Keith L Davis, Cynthia Beam, et al.
Current Oncology (Toronto, Ont.)|January 27, 2021
Real-World Palbociclib Use in HR+/HER2- Advanced Breast Cancer in Canada: The IRIS StudyKatie Mycock, Lin Zhan, Gavin Taylor-Stokes, et al.
Annals of Clinical Biochemistry|May 12, 2016
The economic impact of poor sample quality in clinical chemistry laboratories: results from a global surveyErik P Erdal, Debanjali Mitra, Victor S Khangulov, et al.
BMC Gastroenterology|September 26, 2012
Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitisDebanjali Mitra, Paul Hodgkins, Linnette Yen, et al.
Pageof 5